Tower Research Capital LLC (Trc) Vista Gen Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.12 - $0.3 $2,824 - $7,061	23,537 Added 28.36%	106,526 $13,000
Q4 2022 Feb 10, 2023	BUY	$0.09 - $0.16 $603 - $1,073	6,710 Added 8.8%	82,989 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.14 - $1.07 $8,282 - $63,301	59,160 Added 345.58%	76,279 $12,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $16,215 - $31,878	-18,427 Reduced 51.84%	17,119 $15,000
Q1 2022 May 12, 2022	BUY	$1.14 - $2.09 $16,086 - $29,491	14,111 Added 65.83%	35,546 $44,000

Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $11,222 - $18,547	-6,720 Reduced 23.87%	21,435 $42,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $69,828 - $91,949	26,652 Added 1773.25%	28,155 $78,000
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $84,413 - $135,664	-43,068 Reduced 96.63%	1,503 $5,000
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $84,239 - $131,930	44,571 New	44,571 $95,000
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.94 $12,312 - $36,749	-18,943 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.48 - $1.03 $3,246 - $6,966	6,764 Added 55.54%	18,943 $13,000
Q2 2020 Aug 13, 2020	BUY	$0.37 - $0.61 $4,506 - $7,429	12,179 New	12,179 $6,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.